Detalhe da pesquisa
1.
Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases.
Annu Rev Physiol
; 84: 585-610, 2022 02 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35143332
2.
Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction.
Int J Mol Sci
; 24(3)2023 Jan 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36768859
3.
A New Role for the Aldosterone/Mineralocorticoid Receptor Pathway in the Development of Mitral Valve Prolapse.
Circ Res
; 127(3): e80-e93, 2020 07 17.
Artigo
Inglês
| MEDLINE | ID: mdl-32329663
4.
Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury.
Int J Mol Sci
; 23(12)2022 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35743123
5.
Beneficial Effects of Mineralocorticoid Receptor Antagonism on Myocardial Fibrosis in an Experimental Model of the Myxomatous Degeneration of the Mitral Valve.
Int J Mol Sci
; 21(15)2020 Jul 28.
Artigo
Inglês
| MEDLINE | ID: mdl-32731636
6.
Effect of acute and chronic aldosterone exposure on the retinal pigment epithelium-choroid complex in rodents.
Exp Eye Res
; 187: 107747, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31394103
7.
The Absence of Endothelial Sodium Channel α (αENaC) Reduces Renal Ischemia/Reperfusion Injury.
Int J Mol Sci
; 20(13)2019 Jun 27.
Artigo
Inglês
| MEDLINE | ID: mdl-31252520
8.
Mineralocorticoid receptor antagonism improves diastolic dysfunction in chronic kidney disease in mice.
J Mol Cell Cardiol
; 121: 124-133, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29981797
9.
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease.
J Am Heart Assoc
; : e032971, 2024 Jun 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38842271
10.
NGAL is a Novel Target in Hypertension by Modulating the NCC-Mediated Renal Na Balance.
Hypertension
; 80(9): 1860-1870, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37377014
11.
Neutrophil Gelatinase-Associated Lipocalin From Macrophages Plays a Critical Role in Renal Fibrosis Via the CCL5 (Chemokine Ligand 5)-Th2 Cells-IL4 (Interleukin 4) Pathway.
Hypertension
; 79(2): 352-364, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34794340
12.
Mineralocorticoid Receptor Antagonism Prevents the Synergistic Effect of Metabolic Challenge and Chronic Kidney Disease on Renal Fibrosis and Inflammation in Mice.
Front Physiol
; 13: 859812, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35464084
13.
Endothelial sodium channel activation mediates DOCA-salt-induced endothelial cell and arterial stiffening.
Metabolism
; 130: 155165, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35183546
14.
Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models.
Sci Rep
; 11(1): 2591, 2021 01 28.
Artigo
Inglês
| MEDLINE | ID: mdl-33510370
15.
Mineralocorticoid Receptor and Cardiovascular Disease.
Am J Hypertens
; 31(11): 1165-1174, 2018 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30192914